Investor profile
Takeda Ventures has backed 6 European tech companies across 8 funding rounds between 2005 and 2025, joining rounds totalling €76M. Most active in Healthtech and Fintech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| BiomX | Israel | 1 | €22M |
| Symphogen | Denmark | 1 | €21M |
| Integra Therapeutics | Spain | 2 | €15M |
| Enzyre | Netherlands | 1 | €12M |
| Univercells | Belgium |
| 2 |
| €6.0M |
| Zelluna Immunotherapy | Norway | 1 | €0 |
| Seed |
| €11M |
| 2025-09 |
| Integra Therapeutics | Other | €4.5M | 2021-12 |
| Univercells | Other | €3.0M | 2017-04 |
| Univercells | Early VC | €3.0M | 2015-10 |
